Global High-Priority Regulatory Events — July 23, 2026

23-07-2026

Zaggle Prepaid Ocean Services Limited has invested ₹7,96,00,640 (₹7.96 Crore) in Unobanc Private Limited via a preferential allotment of 62,188 equity shares at ₹10 each. This investment gives Zaggle a 19.9% equity stake in Unobanc, representing a minority but significant ownership position.

• · The investment was made via preferential issue on a private placement basis.
• · Face value of each equity share is ₹10.
• · The investment was previously intimated on July 21, 2026 (letter ZAGGLE/26-27/50).

23-07-2026

Manaksia Coated Metals & Industries Limited has published a newspaper notice regarding an NCLT petition (Company Petition (CAA) No. 57/KB/2026) filed by ICICI Bank Limited against the company, with the hearing scheduled for August 28, 2026, before the NCLT Kolkata Bench. The notice also includes an e-auction sale of secured assets by Tata Capital Housing Finance Limited (TCHFL) scheduled for August 11, 2026, to recover outstanding dues from the company and its co-borrowers/guarantors. The filing indicates the company is facing insolvency proceedings and asset enforcement actions from multiple creditors.

• · The NCLT petition (CAA No. 57/KB/2026) was filed under Sections 230-232 of the Companies Act, 2013, relating to a scheme of amalgamation/arrangement involving JPA Snacks Private Limited and Manaksia Coated Metals & Industries Limited.
• · The hearing for the NCLT petition is scheduled for August 28, 2026, at the Kolkata Bench.
• · The e-auction of secured assets by TCHFL is scheduled for August 11, 2026, from 2:00 PM to 3:00 PM with 5-minute unlimited extensions.
• · The last date for submitting physical bids (with EMD) is August 10, 2026, by 5:00 PM for the TCHFL auction.
• · Property inspection is allowed on August 4, 2026, from 11:00 AM to 5:00 PM after prior appointment.
• · The successful bidder must pay 25% of the purchase price within 24 hours of being declared successful, and the remaining 75% within 15 days from the confirmation of sale.
• · A 1% TDS on the highest bid amount is applicable for the successful bidder.
• · The e-auction for TCHFL properties will be conducted on the portal https://auctionbazaar.com and also via https://BidDeal.in.
• · The ICICI Bank petition details are available at www.icicibank.com/n4p4s.
• · TCHFL property disposal details are available at https://www.tatacapital.com/property-disposal.html.

23-07-2026

Indo National Limited (Nippo Batteries) has acquired an additional 0.75% equity stake in Medcuore Medical Solutions Private Ltd (MMSPL) for a cash consideration of ₹49,93,872 (₹49.94 Lakh), increasing its total shareholding to 61.09%. MMSPL, which manufactures air monitoring systems and air purifiers, reported a sharp increase in turnover to ₹1,45,60,000 in FY26 from ₹35,41,484 in FY25, though this follows a decline from ₹47,68,000 in FY24. The acquisition is not a related-party transaction and is aimed at facilitating business growth and revenue generation.

• · MMSPL was incorporated on June 7, 2020.
• · The acquisition is expected to be completed by FY 2027-28.
• · The shares were acquired based on a valuation report issued by a registered valuer.
• · No governmental or regulatory approvals are required for the acquisition.

23-07-2026

Gentherm reported record quarterly revenue of $416.2 million for Q2 2026, up 11.0% YoY (9.5% ex-FX), driven by strong Automotive Climate and Comfort Solutions growth of 14.1%. However, gross margin contracted to 23.2% from 23.9%, and cash flow from operations dropped sharply to $2.3 million from $31.7 million, partly due to restructuring and M&A expenses. The company raised its full-year 2026 revenue guidance to $1.55B–$1.65B, completed the acquisition of Innovative Medical Equipment, LLC, and announced a new $400 million stock repurchase program.

• · Automotive New Business Awards totaled $690 million in Q2 2026.
• · Selected by two leading North American furniture brands for climate and comfort solutions; fourth consecutive quarter of new home and office customer wins.
• · Automotive Climate and Comfort Solutions outperformed S&P Global's light vehicle production report in relevant markets by 14 percentage points.
• · GAAP diluted EPS was $0.14 vs $0.02 in prior year; adjusted diluted EPS was $0.75 vs $0.54.
• · Full year 2026 guidance raised: Product Revenues $1.55B–$1.65B (from $1.5B–$1.6B), Adjusted EBITDA $185M–$200M (from $175M–$195M), Adjusted Free Cash Flow $85M–$100M (from $80M–$100M).
• · Planned combination with Modine Performance Technologies remains on track to close by early Q4 2026.
• · New stock repurchase program of up to $400 million replaces prior program effective July 27, 2026, with three-year term.
• · Medical revenue ex-FX declined 0.2% YoY, essentially flat.
• · Cash flow from operations decreased sharply to $2.3M from $31.7M due to restructuring and M&A expenses.

23-07-2026

Bleichroeder Acquisition Corp. II has filed Amendment No. 3 to its business combination agreement with Pasqal Holding SAS, a French quantum computing company. The amendment revises the terms of the post-closing equity incentive plan (LTIP), capping the share reserve at 10% of the fully-diluted outstanding shares and requiring further negotiation of vesting criteria based on performance conditions. The transaction continues to progress toward closing, with no changes to the overall deal structure or valuation disclosed.

• · Amendment No. 3 is dated July 22, 2026, and was filed on July 23, 2026.
• · The original Business Combination Agreement was dated February 28, 2026, with prior amendments on May 26, 2026 (Amendment No. 1) and June 25, 2026 (Amendment No. 2).
• · The LTIP will include founder’s warrants (BSPCEs) or free shares (actions gratuites).
• · The LTIP share reserve is capped at 10% of the aggregate number of Surviving Corporation Shares issued and outstanding immediately after the Closing on a fully-diluted and as-converted basis (after giving effect to Parent Shareholder Redemptions).
• · Further edits to the LTIP, including vesting criteria based on performance conditions, will be negotiated in good faith based on recommendations from the Company’s compensation consultant, subject to board approval.

23-07-2026

B&R Technology Merger Corp. priced its initial public offering of 32,500,000 units at $10.00 per unit, raising $325 million. The units will trade on Nasdaq under the symbol BRTMU starting July 21, 2026. The company is a blank-check company formed for mergers or acquisitions, with Citigroup as sole bookrunner.

• · Each unit consists of one Class A ordinary share and one-third of one warrant.
• · Warrants have an exercise price of $11.50 per share.
• · Class A ordinary shares and warrants will trade under symbols BRTM and BRTMW after separate trading begins.
• · Underwriters have a 45-day option to purchase up to 4,875,000 additional units.
• · The registration statement has been declared effective by the SEC.

23-07-2026

India Radiators Limited (Transferor Company) has filed Form INC-28 with the Registrar of Companies, Chennai, on July 23, 2026, following the sanction of its Scheme of Amalgamation with Mercantile Ventures Limited (Transferee Company) by the NCLT, Chennai. The Scheme has become effective from July 23, 2026, resulting in the dissolution of India Radiators Limited without winding up and the dissolution of its Board of Directors and committees. No financial figures or performance metrics are disclosed in this filing.

• · The Scheme was sanctioned by the Hon'ble National Company Law Tribunal, Division Bench (Court-I), Chennai, vide its Order dated July 08, 2026.
• · The certified copy of the NCLT Order was received by the Company prior to filing.
• · The Transferor Company (India Radiators Limited) will be dissolved without winding up.
• · The Board of Directors and any committees of the Transferor Company stand dissolved effective July 23, 2026.

23-07-2026

Cayson Acquisition Corp filed an 8-K reporting that its insiders deposited the fifth monthly extension contribution of $125,000 into the trust account on July 22, 2026, extending the deadline to complete a business combination to as late as March 23, 2027. The company had previously held an extraordinary general meeting on March 18, 2026, to approve up to twelve monthly extensions. No business combination has been announced, and the filing contains no financial results or operational metrics.

• · The extension was approved at an extraordinary general meeting held on March 18, 2026.
• · The original deadline was extended on a monthly basis up to 12 months, until March 23, 2027.
• · The insiders (sponsors, officers, directors, affiliates or designees) are required to lend $125,000 per month to the trust account.
• · The deposited amount increases the per-share redemption price paid upon consummation of a business combination or liquidation.

23-07-2026

Apollo Micro Systems Limited (AMSL) has launched an open offer to acquire up to 1,39,77,911 equity shares (26.00% of the equity share capital) of Premier Explosives Limited at a cash offer price of ₹698 per share, under SEBI (SAST) Regulations. The offer is not conditional on a minimum acceptance level, but if oversubscribed, shares will be accepted on a proportionate basis. The tendering period is scheduled from September 1 to September 15, 2026, with payment for accepted shares by September 29, 2026.

• · The open offer is made under Regulation 3(1) and Regulation 4 of SEBI (SAST) Regulations.
• · The offer is not conditional upon any minimum level of acceptance.
• · The identified date for determining eligible shareholders is August 17, 2026.
• · The last date for a competing offer is August 6, 2026.
• · The Acquirer may withdraw the offer if required statutory approvals are not received or conditions precedent under the SPA are not met.
• · The offer price may be revised upward up to August 28, 2026.

23-07-2026

Mr. Karronn Naresh Bajaj has announced a mandatory open offer to acquire up to 22,88,000 equity shares (26% of voting capital) of Mitshi India Limited at ₹15 per share, triggered by a share purchase agreement to buy 13,70,070 shares (15.57%) from promoters Kumar V Shah and Deepa Kumar Shah for ₹2,05,51,050. The total consideration for the open offer, if fully subscribed, is ₹3,43,20,000. The offer is not conditional on a minimum acceptance level and the acquirer has no intention to delist the company.

• · The open offer is mandatory under Regulation 4 of SEBI (SAST) Regulations, triggered by the SPA dated July 23, 2026.
• · The target company's equity shares are infrequently traded on BSE (Security Code: 523782, Symbol: MITSHI).
• · The detailed public statement (DPS) will be published on or before July 30, 2026.
• · The acquirer will become the promoter of the target company after the transaction, and the sellers will be declassified from promoter category.
• · The offer is not conditional on any minimum acceptance level and is not a competitive bid.

23-07-2026

Meesho Limited's Board approved an additional investment in Meesho Grocery Private Limited (MGPL) of up to INR 75,00,00,000 (Indian Rupees Seventy-Five Crore Only) to support business growth, and approved acquisition of 1 equity share of face value Re.1 in Meesho Payments Private Limited (MPPL) which will raise the Company's stake from 99.99% to 100%, making MPPL a wholly-owned subsidiary. Financials for the targets show MGPL turnover of Rs. 112.10 lakh and net profit of Rs. 6,899.30 lakh, while MPPL shows turnover of Rs.1,104.65 lakh and net loss of Rs.2,471.67 lakh; the move centralizes ownership but involves funding a low-turnover grocery subsidiary and consolidating a payments subsidiary with an existing material loss.

• · MGPL reported turnover of Rs. 112.10 lakh and net profit of Rs. 6,899.30 lakh as on March 31, 2026, despite having a relatively low turnover figure compared with its profit figure (both reported in lakhs).
• · MPPL reported turnover of Rs.1,104.65 lakh and a net loss of Rs.2,471.67 lakh as on March 31, 2026; the acquisition of 1 share is presented to make MPPL a Wholly Owned Subsidiary (WOS).
• · Indicative timelines: MGPL investment to be completed on or before September 15, 2026; MPPL share acquisition to be completed on or before July 30, 2026.
• · AoA amendment: Founders retain Board nomination rights while individually/collectively holding at least 3% or specifically 75,62,14,937 Equity Shares; two largest non-promoter investors holding at least 8.00% (Fully Diluted) get Investor Nominee Director rights (rounded to two decimals, with 7.995% treated as 8.00%).
• · Board meeting started at 2:00 p.m. IST and concluded at 4:30 p.m. IST on July 23, 2026.

23-07-2026

Mercantile Ventures Limited has filed Form INC-28 with the Registrar of Companies, Chennai, on July 23, 2026, making effective the Scheme of Amalgamation of India Radiators Limited (Transferor Company) with Mercantile Ventures Limited (Transferee Company), sanctioned by the NCLT on July 08, 2026. As a result, the authorized share capital of the Transferee Company increases from Rs. 13,009 Lakh to Rs 15.109 Lakh, and India Radiators Limited will be dissolved without winding up. The filing is a routine procedural step to complete the merger, with no negative or flat performance metrics reported.

• · The Scheme was sanctioned by the Hon'ble National Company Law Tribunal, Division Bench (Court–I) Chennai, vide its Order dated July 08, 2026.
• · The certified copy of the NCLT order was received by the Company before filing Form INC-28.
• · Upon effectiveness, the Board of Directors and any committees of India Radiators Limited stand dissolved.
• · The authorized share capital increases from Rs. 13,009 Lakh to Rs 15.109 Lakh, with equity shares increasing from 11,50,90,000 to 11,60,90,000 and preference shares increasing from 1,50,00,000 to 3,50,00,000.

23-07-2026

SKIL Infrastructure Ltd, which is under the Corporate Insolvency Resolution Process (CIRP) by order of the Hon'ble NCLT Mumbai dated February 1, 2024, has informed the stock exchanges that the Eighth Committee of Creditors (CoC) meeting will be held on July 24, 2026, via virtual mode. The company remains in insolvency proceedings with no resolution or revival update provided in this filing.

• · The company has been under CIRP since an NCLT order dated February 1, 2024.
• · This is the Eighth Committee of Creditors meeting, indicating the process has been ongoing for over two years.
• · The meeting will be held virtually on July 24, 2026, at 12:15 PM.
• · No resolution plan or timeline for completion of CIRP has been disclosed in this filing.

23-07-2026

Recode Studios Ltd has completed Phase I of its acquisition of a 33% stake in Aflairza Professionals Private Limited for an aggregate consideration of approximately ₹8.32 Crore. The acquisition, which is in line with the company's existing beauty and cosmetics business, is expected to strengthen its product portfolio and market reach. However, the target company is a newly incorporated entity (May 2026) with only provisional revenue of ₹1.47 Crore for its first six weeks, while its predecessor partnership firm showed steady but modest growth from ₹4.44 Crore (FY24) to ₹8.22 Crore (FY26).

• · Phase I acquisition completed on 23 July 2026; Phase II expected by February 2027.
• · Acquisition price per equity share: ₹285 (Face Value ₹10, Securities Premium ₹275).
• · The target company was incorporated on 16 May 2026 pursuant to conversion of a partnership firm.
• · The acquisition is not a related party transaction.
• · No governmental or regulatory approvals required for the acquisition.

23-07-2026

Canton Strategic Holdings, Inc. (the parent of Tharimmune, Inc.) sold its wholly owned subsidiary Gravitas Life Sciences, LLC to Gravitas Collective Corp. for a $3.5M unsecured promissory note bearing 15% interest, plus potential development milestone payments. The divestiture significantly reduces operating losses: pro forma net loss for FY2025 improves from $(35.9M) to $(25.8M), and for Q1 2026 from $(47.3M) to $(45.5M). However, the company retains a large deferred tax liability of $113.7M and continues to incur substantial unrealized losses from digital asset holdings ($15.0M in Q1 2026).

• · The company retained certain bispecific antibodies assets via Tharimmune SPV1 under a Bill of Sale.
• · Pro forma basic and diluted net loss per share for FY2025 improves from $(1.12) to $(0.81); for Q1 2026 from $(0.23) to $(0.22).
• · Weighted average shares outstanding for FY2025 were 32,049,310; for Q1 2026 were 207,705,905 (reflecting significant dilution).
• · Unrealized loss from digital assets holdings was $15.0M in Q1 2026 and $22.0M in FY2025, unchanged by the divestiture.
• · The promissory note matures on July 17, 2029, with interest payable in kind and compounding semi-annually.

23-07-2026

Century Enka Limited has acquired 37,00,000 additional equity shares of ABREL Century Energy Limited (ABRELCEL) via a rights issue at a cost of ₹3,70,00,000 (face value ₹10 per share). The acquisition maintains the company's 26% shareholding in the SPV to comply with captive power user requirements under the Electricity Act, 2003. ABRELCEL's revenue declined from ₹1,949.10 Lakh in FY 24-25 to ₹1,884.40 Lakh in FY 25-26, a decrease of 3.3%.

• · ABRELCEL was incorporated on 10th March 2022 as a Special Purpose Vehicle for captive power projects (wind & solar).
• · The transaction is a related party transaction but done at arm's length, as per the company.
• · No governmental or regulatory approvals were required for the acquisition.
• · Consideration was cash-based.

23-07-2026

Gloster Limited has filed a draft Scheme of Amalgamation with stock exchanges to merge its two wholly owned subsidiaries, Gloster Lifestyle Limited and Gloster Specialities Limited, into itself. The merger aims to consolidate operations, reduce cost duplication, eliminate inter-company transactions, and streamline regulatory compliance. No financial figures or share exchange ratios are disclosed as the subsidiaries are 100% owned, so no capital restructuring is involved.

• · The Board of Directors approved the draft scheme on 12th November 2025.
• · The Transferor Companies are wholly owned subsidiaries of the Transferee Company.
• · No reorganization or restructuring of capital is involved as the subsidiaries are 100% owned.
• · The scheme is to be filed before the Hon'ble NCLT, Kolkata Bench for approval.
• · Processing fee of ₹29,500 (including GST) was paid to BSE on 22.07.2026.

23-07-2026

Jubilant FoodWorks Limited announced that its wholly owned subsidiary, Jubilant FoodWorks Lanka (Private) Limited, has completed the issuance of 95,271,430 Optionally Convertible Non-Cumulative Preference Shares (OCPS) for an aggregate consideration of LKR 666,900,010 on July 22, 2026. This follows the execution of a Share Subscription and Shareholders' Agreement disclosed on June 15, 2026. The filing is a routine update on a previously announced investment and does not contain any financial performance data or period-over-period comparisons.

• · The issuance was completed on July 22, 2026.
• · The event occurred on July 23, 2026 at 09:40 hours IST.
• · The filing is made under Regulation 30 of SEBI Listing Regulations.
• · No financial performance metrics, revenue, profit, or period-over-period comparisons are provided in this filing.

23-07-2026

The Hon'ble NCLT, New Delhi Bench, has approved the resolution plan for Dion Global Solutions Ltd (Corporate Debtor) submitted by Indus Intellirisk and Intellisense Services Private Limited (Successful Resolution Applicant) under Section 31 of the IBC. The CIRP was initiated in August 2020, and the plan was approved by the Committee of Creditors with 100% voting share in April 2021. The SRA deposited Rs. 80.03 lakh in lieu of the performance bank guarantee, and a monitoring committee will oversee implementation.

• · CIRP initiated on 18 August 2020 by NCLT New Delhi Bench.
• · Resolution plan approved by CoC in 9th meeting on 26 April 2021 with 100% voting share.
• · SRA deposited Rs. 44.63 lakh on 15 May 2021 and Rs. 35.66 lakh on 5 June 2026, totalling Rs. 80.03 lakh in lieu of performance bank guarantee.
• · A monitoring committee comprising CoC, RP, and SRA nominees will oversee implementation.
• · The NCLT order is dated 21 July 2026 but not yet uploaded on the NCLT website.

23-07-2026

Belding India Limited (formerly Synthiko Foils Ltd.) has acquired 100% equity stake in Evolve IT Solutions Private Limited for a cash consideration of ₹10.75 Crore, making Evolve a wholly-owned subsidiary. Evolve specializes in advanced X-ray inspection and security screening technologies, and the acquisition is expected to expand Belding's capabilities in manufacturing, industrial electronics, AI-enabled imaging, and mission-critical security technologies. The target company reported turnover of ₹20.81 Crore in FY 2024-25, ₹14.81 Crore in FY 2023-24, and ₹20.00 Crore in FY 2022-23, showing a 40.5% increase in FY 2024-25 from the prior year but a decline of 26.0% in FY 2023-24 from FY 2022-23.

• · The acquisition is not a related party transaction and has been done at arm's length.
• · Evolve IT Solutions was incorporated on 18/02/2009 and operates from its owned manufacturing and R&D facility at MIDC, Bhosari, Pune.
• · The acquisition is already completed as of the filing date.
• · Belding India Limited was formerly known as Synthiko Foils Limited.

23-07-2026

Orient Cement Limited's Board approved unaudited financial results for Q1 FY27 (quarter ended June 30, 2026) and authorized the acquisition of a 9.04% stake in Vena Energy KN Wind Power Private Limited for a cash consideration of ₹12,34,350. The target operates a 46 MW wind power project in Karnataka, and the acquisition is intended to secure captive renewable energy for the company's cement operations. The financial results were not detailed in this filing, so no performance trends can be assessed.

• · The acquisition is not a related party transaction.
• · The acquisition is expected to be completed on or before August 31, 2026.
• · The target company, Vena Energy KN Wind Power Private Limited, was incorporated on June 18, 2014.
• · The wind power project is located in Mangoli District, Karnataka.
• · The Board meeting started at 5:00 PM and concluded at 6:00 PM on July 23, 2026.

23-07-2026

Aurobindo Pharma Limited, through its wholly owned subsidiary Apitoria Pharma Private Limited, has approved the acquisition of an 80% ownership stake in the Contract Research Services business of A1 Biochem Group for an enterprise value of USD 17 million (USD 13.6 million for its 80% share). The acquisition aims to create a dedicated Contract Research, Development and Manufacturing (CRDMO) platform, expanding Aurobindo's presence in the API lifecycle. A1 Biochem Group generated a turnover of INR 1,024.4 million in FY2025-26 with an EBITDA of INR 465.46 million, though its turnover declined slightly from INR 1,062.2 million in FY2024-25.

• · Acquisition expected to close within 90-120 days, subject to customary approvals.
• · Transaction is not a related party transaction; promoter/promoter group has no interest in the target.
• · A1 Biochem Group has laboratories in Wilmington, North Carolina, USA and Hyderabad, India.
• · The group exports services to Netherlands, France, and Japan.
• · A1 Biochem Labs (India) Private Limited incorporated on November 11, 2021; A1 Biochem Research (India) Private Limited on July 18, 2022; A1 Biochem Labs LLC, USA in September 2015.

23-07-2026

Dynamic Alternatives Fund has commenced an issuer tender offer to repurchase up to 5% of its net assets from shareholders. As of May 29, 2026, the Fund had 38,472,279 shares outstanding with a net asset value of $446,663,160 ($11.61 per share). Shareholders must tender by August 24, 2026, with withdrawals allowed until September 22, 2026; payment will be made at net asset value less any repurchase expenses, with full-redemption shareholders receiving a promissory note.

• · The Fund is a closed-end, non-diversified management investment company registered under the Investment Company Act of 1940.
• · There is no established trading market for the Shares; transfers are strictly limited.
• · Shareholders tendering all their Shares will receive a non-interest bearing, non-transferable promissory note with an initial payment of 95% of estimated value approximately 40 days after the Valuation Date, and a final payment after the annual audit.
• · The Fund may suspend, postpone, or terminate the offer if the Board determines it is advisable.
• · The Fund reserves the right to compulsorily repurchase all Shares of any shareholder whose aggregate value falls below the minimum initial investment.

23-07-2026

Nuvve Holding Corp. received a delisting determination from Nasdaq on July 22, 2026, due to non-compliance with the Periodic Reporting Rule (failure to file its Q1 2026 10-Q), the Bid Price Rule (closing bid price below $1.00), and the Equity Rule (stockholders' equity below $2,500,000). Trading in the company's common stock will be suspended effective July 24, 2026, and the company expects to begin trading on the OTC Pink Limited Information Tier under the symbol 'NVVE'. The company is considering an appeal to the Nasdaq Listing and Hearing Review Council.

• · The delisting determination was issued by the Nasdaq Hearings Panel on July 22, 2026.
• · The company had previously received a Staff delisting notice on April 20, 2026, due to continued non-compliance with the Bid Price Rule.
• · On May 22, 2026, Nasdaq notified the company that non-compliance with the Periodic Reporting Rule could serve as an additional basis for delisting.
• · The Panel's July 9, 2026 decision required filing of the Quarterly Report and compliance with the Equity Rule by July 13, 2026, and compliance with the Bid Price Rule for 20 consecutive business days by July 31, 2026.
• · The company intends to apply for inclusion in the OTCQB tier after initially trading on the Pink Limited Information Tier.

23-07-2026

Akums Drugs and Pharmaceuticals Limited, through its wholly-owned subsidiary Pure and Cure Healthcare Private Limited, has approved the acquisition of Oriflame India Private Limited's manufacturing business for a total cash consideration of INR 56 Crore. The acquisition includes two manufacturing plants in Roorkee, Uttarakhand and Noida, Uttar Pradesh, along with a leased warehouse in Noida, and marks Akums' entry into the color cosmetics segment while expanding its skincare and wellness product capabilities. The transaction is expected to be completed by August 31, 2026, and does not involve any related party transactions or require governmental approvals.

• · The acquisition is through a wholly-owned subsidiary, Pure and Cure Healthcare Private Limited.
• · The trademark and marketing of Oriflame's products in India are not part of the transaction.
• · No prior governmental or regulatory approvals are required for the acquisition.
• · The acquisition is expected to be completed by August 31, 2026.

23-07-2026

ZeroStack Corp. closed a private cryptocurrency financing on July 20, 2026, acquiring 142,232,948 native tokens of the Zero Gravity (0G) blockchain. Investors contributed the tokens to a newly formed subsidiary, Texas Blocker Corp., in exchange for 9,104,614 common shares of ZeroStack. The transaction involved a related party, as Executive Chairman Michael Heinrich is also CEO of Zero Gravity Labs Inc., which received 4,608,864 common shares (50.6% of the blocker shares).

• · The financing was previously announced on March 31, 2026.
• · Shareholder approval was obtained via 'Proposal 6 - Approval of the Continuance Proposal' at the 2026 Annual and Special Meeting.
• · Texas Blocker Corp. became a wholly-owned subsidiary of ZeroStack after the exchange.
• · The transaction is a related-party deal due to Michael Heinrich's dual roles.

23-07-2026

Southern Cross Acquisition I Corp. (NASDAQ: NCOOU) announced the pricing of its $100 million initial public offering of 10,000,000 units at $10.00 per unit, with the units expected to trade on Nasdaq starting July 21, 2026. The SPAC will search for a merger or business combination target without industry or geographic restrictions. The offering is expected to close on July 22, 2026, subject to customary conditions.

• · Each unit consists of one ordinary share, one redeemable warrant, and one right to receive one-fourth of one ordinary share upon consummation of an initial business combination.
• · Each whole redeemable warrant entitles the holder to purchase one ordinary share at an exercise price of $11.50 per share.
• · Once separate trading begins, ordinary shares, warrants, and rights will trade under 'NCO', 'NCOOW', and 'NCOOR', respectively.
• · The underwriters have a 45-day option to purchase up to 1,500,000 additional units to cover over-allotments.
• · The registration statement on Form S-1 (File No. 333-296723) was declared effective by the SEC on July 20, 2026.
• · NCO is a blank check company with no specific industry or geographic target restrictions.

23-07-2026

Aprea Therapeutics received a notification from Nasdaq granting an additional 180-day grace period (until January 19, 2027) to regain compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company initially failed to meet the requirement and its first compliance period ended on July 22, 2026. If the stock does not trade at or above $1.00 for 10 consecutive business days by the new deadline, Nasdaq will initiate delisting proceedings, though the company may appeal.

23-07-2026

Four Leaf Acquisition Corporation amended its charter to extend the deadline to complete an initial business combination from June 22, 2026 to June 22, 2027, with up to twelve additional one-month extensions available. Each monthly extension requires a $75,000 deposit into the trust account. The amendment was approved by the board and stockholders.

• · Original deadline for business combination was June 22, 2026; now extended to June 22, 2027.
• · Extension requires a $75,000 deposit into the trust account per month, with five business days advance notice.
• · Up to $100,000 of trust interest may be used for dissolution expenses.
• · Amendment was adopted under Section 242 of the Delaware General Corporation Law.

23-07-2026

Shore Bancshares Inc. disclosed a delisting notice from Nasdaq after its subsidiary made $10,555 in legal payments to a firm whose partner, director Louis P. Jenkins Jr., served on the Audit Committee, violating Nasdaq’s audit committee independence rules. To resolve the non-compliance, Jenkins resigned from the Audit Committee effective July 16, 2026, and the committee now has four independent members. The disclosure is the Company’s own notification; no Nasdaq action or delisting has been formally imposed yet, but the situation created a material governance risk.

• · Payments totaling $10,555 were made for legal services rendered from February to April 2026, while Jenkins served on the Audit Committee.
• · The violation relates to Nasdaq Listing Rule 5605(c)(2) and Exchange Act Rule 10A-3(b)(1).
• · Jenkins resigned from the Audit Committee effective July 16, 2026, one day before the initial notice to Nasdaq.
• · The Audit Committee now consists of four members, all meeting independence requirements.

23-07-2026

XMax Inc. (XWIN) disclosed that its wholly owned subsidiary, Xmax Beta Holdings Ltd., increased its interest in Preamble X Capital I to over 99.9% via an additional subscription of $8.32 million. Subsequently, Preamble X Capital I subscribed for approximately 48% interests in a private investment fund for $8.0 million, which intends to invest substantially all of its assets in shares of Figure AI Inc. The transactions were completed on July 17 and July 22, 2026, respectively.

• · The applicable management fee percentage for the Company in Preamble X Capital I is 0%.
• · The Fund Manager intends to invest substantially all of its investable assets in shares of common or preferred stock of Figure AI Inc.

23-07-2026

Genco Shipping & Trading Limited filed Amendment No. 22 to its Schedule 14D-9, updating its response to the unsolicited tender offer by Diana Shipping Inc. to acquire all outstanding Genco common shares for $24.80 per share in cash. The amendment only adds a new exhibit (a statement issued by Genco on July 23, 2026) and does not change any previously disclosed information. The filing is purely administrative with no new financial or performance data.

• · The amendment (No. 22) is filed on July 23, 2026, adding a new exhibit (a statement issued by Genco on the same date).
• · No changes were made to the substance of the recommendation or other items in the original Statement.

23-07-2026

Fly-E Group, Inc. received a Nasdaq delinquency notice on July 21, 2026, for failing to timely file its Annual Report on Form 10-K for the period ended March 31, 2026, violating Listing Rule 5250(c)(1). The notice has no immediate effect on listing, but non-compliance could lead to delisting. The company filed the overdue 10-K on July 23, 2026, which should eliminate the need for a formal compliance plan.

• · The company must submit a compliance plan by September 21, 2026, if the 10-K filing is not accepted as curing the deficiency.
• · If a plan is accepted, Nasdaq may grant an extension until January 11, 2027, to regain compliance.
• · The company issued a press release on July 23, 2026, as required by Nasdaq Listing Rule 5810(b).

23-07-2026

FG Merger II Corp. (FGMC), a blank-check company, filed its audited financial statements for the year ended December 31, 2025, along with an 8-K reporting the entry into material agreements related to its IPO. The company completed its IPO on January 30, 2025, raising $80.0M in gross proceeds and placing $80.8M into a trust account, generating investment income of $3.0M. However, the company reported a net loss from operations of $(972,161) and general and administrative expenses of $972,161, reflecting the costs of operating as a pre-business-combination SPAC with no operating revenues.

• · The company's common stock has par value $0.0001; 100,000,000 shares authorized; 2,295,800 issued and outstanding (excluding 8,000,000 shares subject to possible redemption) as of December 31, 2025.
• · The company has not yet commenced any operations and will not generate operating revenues until after a Business Combination.
• · The trust account funds are invested in a money market fund meeting Rule 2a-7 under the Investment Company Act.
• · The company must complete a Business Combination with target(s) having fair market value at least 80% of net assets in the trust account, and must acquire 50% or more of voting securities or a controlling interest.
• · The $15 Private Warrants are exercisable for a period of 10 years from the Business Combination date and are non-redeemable.
• · The company issued 40,000 underwriter units and 7,500 advisor units.
• · 300,000 founder shares were forfeited due to no over-allotment exercise by the underwriter.
• · Total stockholders' equity turned positive from $(2,632) at December 31, 2024 to $389,529 at December 31, 2025.
• · Accounts payable increased from $25,728 to $57,171 year over year.
• · Tax liability of $137,747 was recorded in 2025; none in 2024.

23-07-2026

InspireMD, Inc. received a Nasdaq notice on July 17, 2026, for failing to maintain a minimum bid price of $1.00 per share over 30 consecutive business days, triggering a potential delisting risk. The company has a 180-day compliance period until January 13, 2027, to regain compliance, and may seek an additional 180-day period if eligible. While the notice has no immediate effect on trading, the company faces uncertainty in meeting the listing requirement and may consider a reverse stock split.

• · The non-compliance period was from June 3, 2026 through July 16, 2026.
• · If not compliant by January 13, 2027, the company may be eligible for an additional 180-day period if it meets other listing standards.
• · The company may consider a reverse stock split to cure the deficiency.
• · There is no assurance that the company will regain compliance or maintain other Nasdaq listing requirements.

23-07-2026

Oxford Park Income Fund, Inc. filed a final amendment to its tender offer statement, reporting the results of its offer to purchase up to 5% of its net asset value in shares. The tender offer expired on June 30, 2026, with payments made on July 21, 2026 at net asset values of $17.35 (Class A), $17.33 (Class I), and $17.09 (Class L). The filing confirms the completion of the issuer tender offer under Rule 13e-4.

• · Tender offer expired at 5:00 p.m. Eastern Time on June 30, 2026.
• · Valuation date for tendered shares was June 30, 2026.
• · Payments were remitted to shareholders on July 21, 2026.
• · The Fund paid 100% of the unaudited net asset value for accepted tenders.

23-07-2026

Coatue Innovative Strategies Fund completed a tender offer to repurchase up to $395.8 million of its Class S, Class D, and Class I shares at net asset value as of June 30, 2026. The offer expired on July 15, 2026, with only 179,714.49 Class S shares ($2.8 million) and 43,395.48 Class I shares ($0.7 million) validly tendered and accepted, totaling approximately $3.5 million—far below the maximum. No Class D shares were tendered, indicating very low shareholder participation relative to the offer size.

• · No Class D shares were tendered in the offer.
• · The offer expired at midnight Eastern Time on July 15, 2026.
• · The repurchase price was based on net asset value as of June 30, 2026, minus any early repurchase fee.
• · The filing is a final amendment reporting the results of the tender offer.

23-07-2026

Fortress Private Lending Fund has commenced an issuer tender offer to repurchase up to 2,214,111 of its Class I common shares (approximately 5.0% of outstanding shares) at their net asset value as of July 31, 2026. The offer expires on August 19, 2026, and the company expects to conduct quarterly repurchases at the board's discretion. However, shares are not traded in any market, and no executive officers, trustees, or affiliates intend to tender their shares, which may limit participation.

• · The purchase price will be the net asset value as of July 31, 2026 (or later if extended).
• · The offer expires at one minute past 11:59 p.m. Eastern Time on August 19, 2026.
• · Shares are not traded in any market.
• · No executive officer, trustee, or affiliate intends to tender shares in the offer.
• · The board may amend, suspend, or terminate the repurchase program at any time.
• · The company issued approximately 21,044 shares to insiders in the past 60 days for net proceeds of $507,771.

23-07-2026

Crestline Lending Solutions, LLC filed a final amendment to its tender offer statement, reporting that its offer to purchase up to $17,044,152 worth of its outstanding units expired on July 21, 2026. No Shares were validly tendered prior to expiration, resulting in zero participation in the offer.

• · Offer expired at 11:59 p.m., Eastern Time, on July 21, 2026.
• · The offer price was equal to the net asset value per Share as of June 30, 2026.
• · This is the final amendment to the tender offer statement.

23-07-2026

Barings Private Credit Corporation completed its tender offer to repurchase up to 7,320,222 shares of common stock at a net asset value (NAV) of $19.92 per share as of June 30, 2026. The offer was oversubscribed, with the company accepting only 46.01% of validly tendered shares on a pro rata basis, representing 5.0% of total outstanding shares. The aggregate purchase price was $145.78 million, paid via non-interest-bearing promissory notes, reflecting a 2% early repurchase deduction where applicable.

• · The tender offer expired at 11:59 p.m. Eastern Time on June 30, 2026.
• · Payment was made via non-interest-bearing, non-transferable promissory notes.
• · The NAV per share as of June 30, 2026 was determined on July 20, 2026.
• · The early repurchase deduction of 2% was applied where applicable.